Alpha Crest Capital Management LLC Supernus Pharmaceuticals, Inc. Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $689,865 - $848,494	23,962 Added 48.37%	73,504 $2.49 Million
Q2 2022 Aug 11, 2022	BUY	$25.33 - $34.25 $1.25 Million - $1.7 Million	49,542 New	49,542 $1.43 Million
Q1 2022 May 12, 2022	SELL	$28.51 - $32.9 $925,406 - $1.07 Million	-32,459 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$26.37 - $34.22 $58,778 - $76,276	2,229 Added 7.37%	32,459 $947,000
Q3 2021 Nov 10, 2021	BUY	$23.54 - $31.39 $143,947 - $191,949	6,115 Added 25.36%	30,230 $806,000
Q2 2021 Aug 12, 2021	SELL	$26.72 - $33.19 $30,434 - $37,803	-1,139 Reduced 4.51%	24,115 $743,000
Q1 2021 May 13, 2021	BUY	$24.15 - $31.45 $162,505 - $211,627	6,729 Added 36.32%	25,254 $661,000
Q4 2020 Feb 12, 2021	SELL	$17.7 - $25.81 $148,609 - $216,700	-8,396 Reduced 31.19%	18,525 $466,000
Q3 2020 Nov 12, 2020	BUY	$20.2 - $25.05 $543,804 - $674,371	26,921 New	26,921 $561,000
Q2 2020 Aug 12, 2020	SELL	$17.09 - $24.89 $643,438 - $937,108	-37,650 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$14.45 - $24.69 $388,618 - $664,012	26,894 Added 250.04%	37,650 $677,000
Q4 2019 Feb 12, 2020	SELL	$19.93 - $29.13 $397,483 - $580,968	-19,944 Reduced 64.96%	10,756 $255,000
Q3 2019 Nov 12, 2019	BUY	$25.47 - $33.37 $427,896 - $560,616	16,800 Added 120.86%	30,700 $844,000
Q2 2019 Aug 12, 2019	SELL	$29.96 - $38.87 $284,620 - $369,265	-9,500 Reduced 40.6%	13,900 $460,000
Q1 2019 May 10, 2019	BUY	$32.77 - $41.99 $291,653 - $373,711	8,900 Added 61.38%	23,400 $820,000
Q4 2018 Feb 11, 2019	BUY	$30.84 - $49.51 $447,180 - $717,895	14,500 New	14,500 $482,000

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

Black Rock Inc. New York, NY

10.4M
Shares

$376 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.13M
Shares

$221 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.1M
Shares

$184 Million
2.64% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.88M
Shares

$104 Million
0.02% of portfolio
Macquarie Group LTD Australia, C3

2.63M
Shares

$95.1 Million
0.09% of portfolio

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account